INBRAIN NEUROELECTRONICS

INBRAIN Neuroelectronics is a Barcelona-based medical technology company developing graphene-based brain-computer interface (BCI) therapeutics that decode and modulate neural signals with high resolution. Spun off from the EU Graphene Flagship project, it builds AI-powered, ultrathin neural implants to treat disorders such as Parkinson's disease, holding FDA Breakthrough Device Designation and running first-in-human studies with the University of Manchester and Microsoft.